Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Actinogen reports cognition data on Xanamem in healthy elderly subjects

Oct. 3, 2019

New GABRA5 inverse agonists discovered at Shanghai SIMR Biotech

Oct. 3, 2019

Adynxx receives funding award to develop nonopioid chronic pain product candidate

Oct. 3, 2019

US Department of Health & Human Services and collaborators describe D1 receptor PAMs

Oct. 3, 2019

First patient dosed in global phase III pivotal study of zilucoplan for gMG

Oct. 3, 2019

In seizures ER stress is best bad option

Oct. 3, 2019

Lundbeck discloses antibodies targeting tau

Oct. 2, 2019

Annexon reports phase Ib data on ANX-005 in Guillain-Barre syndrome

Oct. 1, 2019

Tavapadon results in improvement of motor symptoms in subjects with early-stage PD

Oct. 1, 2019

Anxious mitochondria shut down under stress

Oct. 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...